Last update 23 Jan 2025

MIOS x CES

Basic Info

Related Targets
MIOSCES

Related

1
Drugs associated with MIOS x CES
Tanshinone IIA
Target
CES x MIOS
Mechanism
CES inhibitors [+1]
Active Org.
Royal Holloway University of LondonRoyal Holloway University of London [+2]
Originator Org.
Changhua Christian Hospital
Active Indication
Glioblastoma [+3]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
3
Clinical Trials associated with MIOS x CES
ChiCTR2400093487
/ RecruitingEarly Phase 1IIT
Clinical efficacy and safety evaluation of dissolving acupoint microneedles with tanshinone IIA in the treatment of chronic stable angina
ChiCTR1800017926
/ SuspendedNot ApplicableIIT
Safety and efficacy of topical Tanshinone gel treatment of infantile hemangioma: a prospective, multicenter, self-controlled clinical trial.
ChiCTR-TQR-14005142
/ RecruitingNot ApplicableIIT
Therapeutic effects of tanshinone IIA towards early renal damage in patients with type 2 diabetes
100 Clinical Results associated with MIOS x CES
Login to view more data
100 Translational Medicine associated with MIOS x CES
Login to view more data
0 Patents (Medical) associated with MIOS x CES
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free